Detection of IDH1 Mutation in cfDNA and Tissue of Adult Diffuse Glioma with Allele-Specific qPCR

BACKGROUND: The World Health Organization (WHO) classification of central nervous system (CNS) tumors necessitates testing of isocitrate dehydrogenase (IDH) 1/2 gene mutation in patients with adult-type diffuse glioma (ADG) for better disease management. In clinical practice, the testing of IDH1 is...

Descripción completa

Detalles Bibliográficos
Autores principales: Husain, Adil, Mishra, Sridhar, Siddiqui, Mohammed Haris, Husain, Nuzhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334107/
https://www.ncbi.nlm.nih.gov/pubmed/36974551
http://dx.doi.org/10.31557/APJCP.2023.24.3.961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334107/
https://www.ncbi.nlm.nih.gov/pubmed/36974551
http://dx.doi.org/10.31557/APJCP.2023.24.3.961

Ejemplares similares